Two of the world’s largest food companies are under mounting pressure from investors and regulators following extensive baby formula recalls that have sickened dozens of infants worldwide.
Nestle initiated widespread product withdrawals in December throughout Europe, Asia, and the Americas due to potential contamination with cereulide, a harmful toxin causing nausea and vomiting in babies.
The contamination crisis led to a public video apology from Nestle’s newly appointed CEO Philipp Navratil and has also impacted competing manufacturers including Danone and private company Lactalis.
French regulatory agencies have launched formal investigations into how the companies managed the product withdrawals, while consumers continue questioning why the recalls took so long to implement. Investors are demanding detailed financial impact reports when Nestle releases annual earnings Thursday and Danone follows Friday.
When contacted, Danone refused to provide comment, while Nestle stated its priority remains restocking inventory.
“I would have expected a little more proactivity and transparency in terms of communication,” stated Kai Lehmann, a portfolio manager at Nestle investor Flossbach von Storch. “This is precisely what Philipp Navratil promised when he took office.”
The contamination scandal compounds existing difficulties for Navratil as he attempts to boost lackluster sales volume at the $260 billion consumer products corporation, which already faces pressure from U.S. trade tariffs and customers switching to lower-cost alternatives.
While Nestle maintains it doesn’t anticipate major financial losses, Lehmann questioned whether the company’s assessment – claiming less than 0.5% of total sales are impacted – remains accurate. Investment firm Jefferies analyst David Hayes estimates Nestle’s complete exposure at 1.6 billion euros ($1.9 billion).
“The downstream effects are likely to be greater, without question,” Lehmann commented, condemning what he described as Nestle’s gradual information disclosure approach. Nestle maintains it has responded quickly and proactively throughout the crisis.
Six industry experts, financial analysts, and affected consumers who spoke with Reuters indicate both companies face significant challenges rebuilding consumer confidence.
“In the infant formula business, your reputation is everything,” explained Tom Booijink, senior dairy specialist for Europe and Africa at RaboResearch.
For Paul Jamieson, a father from Northumberland, England, whose daughter became ill after consuming Nestle-manufactured formula, confidence has been completely lost. “When that trust is compromised, it’s very difficult to feel comfortable continuing with those products,” he explained.
French authorities have determined that Chinese manufacturer Cabio Biotech supplied the contaminated arachidonic acid (ARA) oil containing cereulide. Companies including Nestle and Danone have scrambled to find alternative suppliers while increasing manufacturing output.
Cabio Biotech has not responded to requests for comment.
Danone faces particularly high stakes: approximately 17% of total company profits derive from Chinese infant formula sales, compared to under 2% for Nestle, according to Jefferies’ Hayes. Chinese consumers remain extremely cautious about contamination issues following previous food safety crises.
Danone stock prices have dropped over 5% this year, while Nestle shares have bounced back from a late January decline.
Both corporations risk significant sales losses and reduced market position. Danone’s robust Chinese operations helped exceed third-quarter sales expectations, while Nestle’s NAN formula brand, previously a bright spot against declining Gerber sales, has been swept into the recall crisis.
Several competitors are already capitalizing on the situation. German family-owned brand HiPP reported to Reuters a dramatic surge in customer demand and has ramped up production accordingly. However, New Zealand’s a2 Milk stated it doesn’t anticipate substantial gains.
Hayes suggested the recalls might force Navratil to reduce Nestle’s volume-growth projections by roughly 100 basis points.
“It might be unfair, but people may ask if (Navratil) is unable to really control and avoid these things because (Nestle’s) just too much of a Goliath to oversee,” Hayes commented.
